
Dogwood Therapeutics Investor Relations Material
Latest events

Q3 2024
Dogwood Therapeutics

Q1 2025
8 May, 2025

Q4 2024
31 Mar, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Dogwood Therapeutics Inc
Access all reports
Dogwood Therapeutics Inc. is a biopharmaceutical company focused on the discovery and development of innovative therapies targeting complex diseases. Utilizing advanced scientific research and proprietary technology platforms, the company aims to address unmet medical needs across therapeutic areas such as oncology, immunology, and infectious diseases. Dogwood Therapeutics is engaged in preclinical and clinical research, partnering with healthcare organizations and research institutions to advance potential treatments. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
DWTX
Country
🇺🇸 United States